BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

368 related articles for article (PubMed ID: 27207096)

  • 1. Should New "No Ink On Tumor" Lumpectomy Margin Guidelines be Applied to Ductal Carcinoma In Situ (DCIS)? A Retrospective Review Using Shaved Cavity Margins.
    Merrill AL; Tang R; Plichta JK; Rai U; Coopey SB; McEvoy MP; Hughes KS; Specht MC; Gadd MA; Smith BL
    Ann Surg Oncol; 2016 Oct; 23(11):3453-3458. PubMed ID: 27207096
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Implications of New Lumpectomy Margin Guidelines for Breast-Conserving Surgery: Changes in Reexcision Rates and Predicted Rates of Residual Tumor.
    Merrill AL; Coopey SB; Tang R; McEvoy MP; Specht MC; Hughes KS; Gadd MA; Smith BL
    Ann Surg Oncol; 2016 Mar; 23(3):729-34. PubMed ID: 26467458
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Similar rates of residual disease in patients with DCIS within 2 mm of lumpectomy margin regardless of the presence of invasive carcinoma.
    Kelly BN; Kantor O; Tang R; Coopey SB; Smith BL; Lanahan CR; Korotkin JE; Specht MC
    Breast Cancer Res Treat; 2021 Apr; 186(3):807-814. PubMed ID: 33247799
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of Cavity Shave Margins on Margin Status in Patients with Pure Ductal Carcinoma In Situ.
    Howard-McNatt M; Dupont E; Tsangaris T; Garcia-Cantu C; Chiba A; Berger AC; Levine EA; Gass JS; Ollila DW; Chagpar AB;
    J Am Coll Surg; 2021 Apr; 232(4):373-378. PubMed ID: 33346081
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cost-effectiveness of surgeon performed intraoperative specimen ink in breast conservation surgery.
    Van Den Bruele AB; Jasra B; Smotherman C; Crandall M; Samiian L
    J Surg Res; 2018 Nov; 231():441-447. PubMed ID: 30278966
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The value of breast lumpectomy margin assessment as a predictor of residual tumor burden in ductal carcinoma in situ of the breast.
    Neuschatz AC; DiPetrillo T; Steinhoff M; Safaii H; Yunes M; Landa M; Chung M; Cady B; Wazer DE
    Cancer; 2002 Apr; 94(7):1917-24. PubMed ID: 11932892
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lumpectomy specimen margins are not reliable in predicting residual disease in breast conserving surgery.
    Tang R; Coopey SB; Specht MC; Lei L; Gadd MA; Hughes KS; Brachtel EF; Smith BL
    Am J Surg; 2015 Jul; 210(1):93-8. PubMed ID: 25613784
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A comparison of ink-directed and traditional whole-cavity re-excision for breast lumpectomy specimens with positive margins.
    Gibson GR; Lesnikoski BA; Yoo J; Mott LA; Cady B; Barth RJ
    Ann Surg Oncol; 2001 Oct; 8(9):693-704. PubMed ID: 11597009
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluating the relationship between ductal carcinoma in situ, calcifications, and margin status in patients undergoing breast conserving surgery.
    Bruenderman EH; Bhutiani N; Mercer MK; McMasters KM; Sanders MAG; Ajkay NL
    J Surg Oncol; 2019 May; 119(6):694-699. PubMed ID: 30742316
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Margins in breast cancer: How much is enough?
    Pilewskie M; Morrow M
    Cancer; 2018 Apr; 124(7):1335-1341. PubMed ID: 29338088
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Current margin practice and effect on re-excision rates following the publication of the SSO-ASTRO consensus and ABS consensus guidelines: a national prospective study of 2858 women undergoing breast-conserving therapy in the UK and Ireland.
    Tang SS; Kaptanis S; Haddow JB; Mondani G; Elsberger B; Tasoulis MK; Obondo C; Johns N; Ismail W; Syed A; Kissias P; Venn M; Sundaramoorthy S; Irwin G; Sami AS; Elfadl D; Baggaley A; Remoundos DD; Langlands F; Charalampoudis P; Barber Z; Hamilton-Burke WLS; Khan A; Sirianni C; Merker LAG; Saha S; Lane RA; Chopra S; Dupré S; Manning AT; St John ER; Musbahi A; Dlamini N; McArdle CL; Wright C; Murphy JO; Aggarwal R; Dordea M; Bosch K; Egbeare D; Osman H; Tayeh S; Razi F; Iqbal J; Ledwidge SFC; Albert V; Masannat Y
    Eur J Cancer; 2017 Oct; 84():315-324. PubMed ID: 28865259
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Defining the clinical target volume for patients with early-stage breast cancer treated with lumpectomy and accelerated partial breast irradiation: a pathologic analysis.
    Vicini FA; Kestin LL; Goldstein NS
    Int J Radiat Oncol Biol Phys; 2004 Nov; 60(3):722-30. PubMed ID: 15465188
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of specimen radiography in breast-conserving therapy of ductal carcinoma in situ.
    Lange M; Reimer T; Hartmann S; Glass Ä; Stachs A
    Breast; 2016 Apr; 26():73-9. PubMed ID: 27017245
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Early Adoption of the SSO-ASTRO Consensus Guidelines on Margins for Breast-Conserving Surgery with Whole-Breast Irradiation in Stage I and II Invasive Breast Cancer: Initial Experience from Memorial Sloan Kettering Cancer Center.
    Rosenberger LH; Mamtani A; Fuzesi S; Stempel M; Eaton A; Morrow M; Gemignani ML
    Ann Surg Oncol; 2016 Oct; 23(10):3239-46. PubMed ID: 27411549
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identifying Factors and Techniques to Decrease the Positive Margin Rate in Partial Mastectomies: Have We Missed the Mark?
    Edwards SB; Leitman IM; Wengrofsky AJ; Giddins MJ; Harris E; Mills CB; Fukuhara S; Cassaro S
    Breast J; 2016 May; 22(3):303-9. PubMed ID: 26854189
    [TBL] [Abstract][Full Text] [Related]  

  • 16. No Ink on Ductal Carcinoma
    Fregatti P; Gipponi M; Depaoli F; Murelli F; Guenzi M; Bonzano E; Ceppi M; Friedman D
    Anticancer Res; 2019 Jan; 39(1):459-466. PubMed ID: 30591495
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Factors Associated With Positive Margins in Women Undergoing Breast Conservation Surgery.
    Murphy BL; Boughey JC; Keeney MG; Glasgow AE; Racz JM; Keeney GL; Habermann EB
    Mayo Clin Proc; 2018 Apr; 93(4):429-435. PubMed ID: 29439832
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Effect of Lumpectomy and Cavity Shave Margin Status on Recurrence and Survival in Breast-Conserving Surgery.
    Abdelsattar JM; Afridi FG; Dai Z; Yousaf N; Seldomridge A; Battin AO; Wen S; Gray D; Marsh JW; Cowher MS; Partin JF; Hazard-Jenkins H; Lupinacci K
    Am Surg; 2023 Mar; 89(3):424-433. PubMed ID: 34196595
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Is the systematic circumferential tumor cavity shaving a representative sample for the remaining mammary gland? About 75 cases.
    Bouzaiene H; Triki A; Ghalleb M; Chemlali M; Benzarti Z; Ben Hassouna J; Gammoudi A; Rahal K
    Breast; 2017 Oct; 35():27-31. PubMed ID: 28644994
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Separate cavity margin sampling at the time of initial breast lumpectomy significantly reduces the need for reexcisions.
    Cao D; Lin C; Woo SH; Vang R; Tsangaris TN; Argani P
    Am J Surg Pathol; 2005 Dec; 29(12):1625-32. PubMed ID: 16327435
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.